DENTSPLY SIRONA (NASDAQ:XRAY) Issues Earnings Results, Misses Expectations By $0.21 EPS

DENTSPLY SIRONA (NASDAQ:XRAY) announced its quarterly earnings data on Thursday. The medical instruments supplier reported $0.26 EPS for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.21), Zacks reports. DENTSPLY SIRONA had a positive return on equity of 12.62% and a negative net margin of 10.59%. DENTSPLY SIRONA updated its FY 2025 guidance to 1.800-2.000 EPS.

DENTSPLY SIRONA Trading Down 8.8 %

NASDAQ:XRAY traded down $1.66 during trading hours on Thursday, hitting $17.15. The company had a trading volume of 6,160,723 shares, compared to its average volume of 2,461,708. The company has a market capitalization of $3.41 billion, a PE ratio of -8.28, a price-to-earnings-growth ratio of 1.80 and a beta of 0.96. The stock has a 50-day moving average price of $18.90 and a 200 day moving average price of $21.58. DENTSPLY SIRONA has a 52 week low of $17.09 and a 52 week high of $34.91. The company has a debt-to-equity ratio of 0.72, a current ratio of 1.25 and a quick ratio of 0.84.

DENTSPLY SIRONA Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Investors of record on Friday, March 28th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 3.73%. DENTSPLY SIRONA’s dividend payout ratio (DPR) is currently -30.92%.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on XRAY shares. Wells Fargo & Company started coverage on DENTSPLY SIRONA in a report on Friday, February 14th. They set an “equal weight” rating and a $20.00 price objective on the stock. StockNews.com raised DENTSPLY SIRONA from a “hold” rating to a “buy” rating in a report on Tuesday, February 18th. Robert W. Baird decreased their target price on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating on the stock in a report on Friday, November 8th. Morgan Stanley decreased their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an “overweight” rating on the stock in a report on Tuesday, December 17th. Finally, Evercore ISI reiterated an “in-line” rating and set a $20.00 target price on shares of DENTSPLY SIRONA in a research report on Tuesday, January 7th. Ten research analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $24.50.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.